The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Gene Expression Market Through 2030?
The gene expression market has seen considerable growth over recent years. It is projected to expand from $12.67 billion in 2025 to $14.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be ascribed to elements like increased academic genomics research funding, a rise in the prevalence of chronic and genetic diseases, the initial adoption of microarray technologies, the expansion of pharmaceutical R&D pipelines, and the growing application of PCR-based techniques.
The gene expression market is projected to expand significantly over the coming years, reaching $22.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This anticipated growth is driven by several factors, including advancements in RNA sequencing technologies, a heightened emphasis on precision medicine, the expansion of clinical diagnostics applications, the incorporation of AI into gene expression data analysis, and increased investments within the biotechnology industry. Key trends expected during this period involve the broader adoption of single-cell gene expression analysis, a rise in the application of spatial transcriptomics, increased demand for high-throughput PCR platforms, the growing integration of multi-omics approaches, and the standardization of gene expression workflows.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp
What Influential Factors Are Boosting The Gene Expression Market Demand?
The anticipated expansion of the gene expression market is significantly influenced by the increasing prevalence of chronic diseases. These conditions are defined as enduring medical ailments that last for an extended duration, usually exceeding three months. Gene expression analysis finds application in chronic disease management by aiding in the comprehension of their underlying molecular processes, the discovery of potential biomarkers, and the formulation of precise treatment strategies. As an illustration, data from June 2024, sourced from the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, though not severe enough for a diabetes classification) in 2023. This represented an 18% increase from the 3,065,825 cases recorded in 2022. Consequently, the expanding incidence of chronic diseases is poised to fuel the expansion of the gene expression market.
How Is Segment Classification Applied In The Gene Expression Market?
The gene expression market covered in this report is segmented –
1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products
2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation
3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis
4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications
Subsegments:
1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents
2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays
3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables
What Trends Are Influencing The Gene Expression Market?
Leading companies in the gene expression market are prioritizing the creation of innovative products, such as gene detection assays, to achieve a competitive edge and increase their revenue. Within gene expression, a gene detection assay is a technique for identifying and measuring the presence of genetic molecules, offering insights into the activity and quantity of particular genes. For example, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by launching the RNAscope Plus smRNA-RNA detection assay. This novel assay permits the concurrent fluorescent identification of a small regulatory RNA alongside three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution. Tailored for extensive studies, the assay is compatible with the Leica Bond Rx platform and is offered as a manual assay for straightforward use. These therapeutic nucleic acids possess the capability to modulate the expression and functionality of specific target genes, thus enabling the development of personalized treatments for inherited or acquired diseases that have proven resistant to conventional therapies.
Who Are The Firms Contributing To The Gene Expression Market Ecosystem?
Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation
Access The Complete Gene Expression Market Report:
https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report
Which Region Accounts For The Highest Share Of The Gene Expression Market?
North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Gene Expression Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp
Browse Through More Reports Similar to the Global Gene Expression Market 2026, By The Business Research Company
Gene Expression Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report
Protein Expression Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
